HIV-related neurological syndromes reduce health-related quality of life
- PMID: 16018155
- DOI: 10.1017/s0317167100003978
HIV-related neurological syndromes reduce health-related quality of life
Abstract
Background: Human immunodeficiency virus (HIV) infection frequently results in neurological complications but the impact of different neurological syndromes on patients' quality of life remains unknown.
Methods: We investigated health-related quality of life (HRQoL) parameters among HIV/Acquired Immune Deficiency Syndrome (AIDS) patients with and without neurological disease, including 11 dimensions of HRQoL within the Medical Outcomes Short-form Health Survey-HIV.
Results: Comparisons of sociodemographic and systemic clinical variables did not differ between HIV/AIDS patients with (n=94) and without (n=75) neurological disease. However, patients with neurological diseases exhibited significantly lower HRQoL scores compared to matched controls, which was most evident among HIV/AIDS patients with cognitive impairment and sensory neuropathy. Prospective analysis revealed diminishing HRQoL scores prior to neurological diagnosis followed by a progressive and sustained improvement in HRQoL scores after intervention over a 96-week period.
Conclusions: These studies indicate that while HIV-related neurological diseases are associated with reduced HRQoL scores, enhanced neurological care has a positive impact on HIV/AIDS patients' overall well-being.
Similar articles
-
Peripheral neuropathy and quality of life of adults living with HIV/AIDS in the Rulindo district of Rwanda.SAHARA J. 2012;9(2):88-94. doi: 10.1080/17290376.2012.683582. SAHARA J. 2012. PMID: 23237043
-
Health-related quality of life and associated factors in people with HIV: an Irish cohort study.Health Qual Life Outcomes. 2016 Aug 5;14(1):115. doi: 10.1186/s12955-016-0517-4. Health Qual Life Outcomes. 2016. PMID: 27495166 Free PMC article.
-
Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.AIDS Care. 2016 Jul;28(7):904-12. doi: 10.1080/09540121.2016.1173639. Epub 2016 Apr 21. AIDS Care. 2016. PMID: 27098289
-
Functional consequences of HIV-associated neuropsychological impairment.Neuropsychol Rev. 2009 Jun;19(2):186-203. doi: 10.1007/s11065-009-9095-0. Epub 2009 May 27. Neuropsychol Rev. 2009. PMID: 19472057 Free PMC article. Review.
-
Managing HIV. Part 5: Treating secondary outcomes. 5.4 HIV-induced neurological disease.Med J Aust. 1996 Apr 1;164(7):414-7. Med J Aust. 1996. PMID: 8609853 Review. No abstract available.
Cited by
-
Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.J Neuroimmune Pharmacol. 2012 Jun;7(2):319-31. doi: 10.1007/s11481-011-9310-7. Epub 2011 Sep 15. J Neuroimmune Pharmacol. 2012. PMID: 21918813 Review.
-
Incident neuropathy in HIV-infected patients on HAART.AIDS Res Hum Retroviruses. 2010 Jul;26(7):759-65. doi: 10.1089/aid.2009.0276. AIDS Res Hum Retroviruses. 2010. PMID: 20624077 Free PMC article.
-
NeuroAIDS: a watershed for mental health and nervous system disorders.J Psychiatry Neurosci. 2009 Mar;34(2):83-5. J Psychiatry Neurosci. 2009. PMID: 19270758 Free PMC article. No abstract available.
-
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.Pain Med. 2013 Jul;14(7):1039-47. doi: 10.1111/pme.12084. Epub 2013 Apr 8. Pain Med. 2013. PMID: 23565581 Free PMC article. Clinical Trial.
-
Contribution of CNS cells in NeuroAIDS.J Pharm Bioallied Sci. 2010 Oct;2(4):300-6. doi: 10.4103/0975-7406.72129. J Pharm Bioallied Sci. 2010. PMID: 21180461 Free PMC article.